Planned Solutions’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$221K Hold
950
– – 0.06% 149
2026
Q2
$201K Buy
+950
New +$186K 0.06% 153
2024
Q4
– Sell
-950
Closed -$147K – 239
2024
Q3
$147K Buy
+950
New +$142K 0.06% 148
2024
Q1
– Sell
-950
Closed -$131K – 202
2023
Q4
$131K Buy
+950
New +$125K 0.06% 140
2021
Q1
– Sell
-390
Closed -$46K – 146
2020
Q4
$46K Hold
390
– – 0.04% 215
2020
Q3
$45K Buy
+390
New +$46.1K 0.04% 166

Other funds holding DGX

Planned Solutions's DGX Position: Q3 2026 in Review

Planned Solutions held its Quest Diagnostics (DGX) position steady in Q3 2026 at 950 shares worth $221K. The position accounts for 0.06% of the portfolio, ranked #149.

Planned Solutions first reported a position in DGX in Q3 2020 and has held it in 6 quarters since. 162 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Planned Solutions held 950 shares of Quest Diagnostics worth $221K as of Q3 2026.
  • Planned Solutions left its Quest Diagnostics share count unchanged in Q3 2026.
  • Quest Diagnostics made up 0.06% of Planned Solutions's portfolio in Q3 2026, its #149 holding.
  • Planned Solutions first reported a position in Quest Diagnostics in Q3 2020 and has held it in 6 quarters since.
  • 162 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Planned Solutions's 13F filing for Q3 2026, filed 19 Oct 2026.